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Background: Some recent studies have suggested that laparoscopic surgery for colorectal cancer may provide a
potential survival advantage when compared with open surgery. This study aimed to compare cancer-related
survivals of patients who underwent laparoscopic or open resection of colon cancer in the same, high volume
tertiary center.
Methods: Patients who had undergone elective open or laparoscopic surgery for colon cancer between January
2002 and December 2010 were analyzed. A clinical database was prospectively compiled. Survival analysis was
calculated by using the Kaplan-Meier method.
Results: A total of 460 resections were performed. There were no significant differences between the laparoscopic
(n = 227) and the open group (n = 233) apart from tumor stage: stage I tumors were more frequent in the
laparoscopic group whereas stage II tumors were more frequent in the open group. The mean number of
harvested lymph nodes was significantly higher in the laparoscopic than in the open group (20.0 ± 0.7 vs 14.2 ± 0.5,
P < 0.01). The 5-year cancer-related survival for patients undergoing laparoscopic resection was significantly higher
than that following open resections (83.1% vs 68.5%, P = 0.01). By performing a stage-to-stage comparison, we
found that the improvement in survival in the laparoscopic group occurred mainly in patients with stage II tumors.
Conclusions: Our study shows a survival advantage for patients who had undergone laparoscopic surgery for stage
II colon cancer. This may be correlated with a higher number of harvested lymph nodes and thus a better stage
stratification of these patients.
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Laparoscopic surgery for colon cancer is now practiced
widely, with proven short-term benefits for patient re-
covery. Several studies have shown that it is possible to
have reduced hospital stay, earlier return of bowel func-
tion, better pulmonary function and reduced morbidity
in comparison with open surgery [1-5]. At the beginning
of the laparoscopic era, some concerns were raised* Correspondence: fabio.cianchi@unifi.it
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unless otherwise stated.regarding the oncological outcome of this approach in
the treatment of colorectal cancer. However, data from
randomized trials and meta-analyses have definitively
established that laparoscopic colonic surgery is at least
equivalent to open surgery [2,6-9].
Whether the advantage of fewer complications and
better short-term outcomes can be translated into better
patient survival is controversial. Lacy et al. [10] have
recently reported some unexpected, positive results
regarding long-term survival of patients submitted to
laparoscopic colon cancer resection within a random-
ized, controlled trial. These authors demonstrated a sig-
nificantly higher tumor-related survival in patients who. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with open surgery, and this survival advantage was more
pronounced in patients with stage III tumors. Other
reports, although from retrospective, non-randomized
studies, are in line with these results [11-14], showing
potential survival benefits for patients undergoing
laparoscopic surgery compared with historical series of
conventional open surgery.
A number of hypotheses have been proposed to explain
this beneficial oncological role of laparoscopic surgery in
the treatment of colon cancer. In particular, laparoscopic
resection is known to attenuate the surgical stress and sys-
temic inflammatory response following surgery when
compared with open surgery [15-17]. As a consequence,
the postoperative immune function is better preserved
with laparoscopic surgery, which may lead to a significant
increase in the patient’s resistance to cancer.
The purpose of this study was to compare the cancer-
related survival of patients undergoing laparoscopic and
open surgery for non-metastatic colon cancer in the
same, high volume tertiary center.
Methods
Patients
A retrospective cohort study was performed by comparing
patients undergoing laparoscopy to those undergoing open
resection for colon cancer (at least 15 cm above the
anal verge) with curative intent between January 2002 and
December 2010 at the Center of Minimally Invasive
Oncological Surgery, University of Florence, Italy. Cases
were identified through a prospectively maintained data-
base. During the study period, from 2002 to 2005, the
choice of surgical approach was decided mainly by sur-
geons’ preference and patients’ choice. During this period,
most operations were performed by three colorectal staff
surgeons. Two performed both laparoscopic and open sur-
gery, while the other performed only open operations. With
the progressive maturation of laparoscopic techniques,
laparoscopic surgery has been offered to all suitable patients
since 2005. Postoperative complications were defined ac-
cording to the Clavien-Dindo classification [18]. All patients
were followed postoperatively according to a protocol
which includes physical examination, serum carcinoem-
bryonic antigen determination, abdominal ultrasonography
or computed tomography, and chest x-ray every 6 months.
Total colonoscopy was performed every year. All patients
were thoroughly informed about the study and gave written
consent for the investigation. The study which was in full
compliance with the Declaration of Helsinki, was approved
by the ethics committee of Careggi University Hospital.
Surgical technique
Surgery was performed with curative intent for all the
patients in this study. Therefore, patients with residualmacroscopic tumor after surgery, a secondary neoplasia
or distant metastases were excluded from the study.
Patients who had been converted to open surgery,
mainly for huge, locally advanced lesions, or those with
tumors associated with familial adenomatous polyposis
or inflammatory bowel diseases, were also excluded. All
laparoscopic procedures were performed through a stan-
dardized medial-to-lateral approach as previously de-
scribed [19]. Briefly, this approach begins with proximal
ligation of vascular pedicles, subsequent medial-to-
lateral exploration of the retroperitoneum for identifica-
tion and protection of important structures (e.g., duode-
num, ureter), followed by mobilization and resection of
the bowel with anastomosis. Dissection was performed
in the majority of patients by ultrasonic dissectors. The
specimen was extracted through an incision at a conveni-
ent site in the abdominal wall, protected by a wound pro-
tector, just large enough to allow specimen extraction.
In case of proximal tumors, anastomosis was performed
either intra- or extracorporeally. A left-sided or rectal
anastomosis was performed using a circular stapler which
was inserted transanally. Open resections were performed
through a midline incision in a standard manner.
Operative techniques, standardized for open and laparo-
scopic surgery at our institution, included lymphadenec-
tomy according to tumor location as previously described
[19]. Briefly, for proximal tumors, (i.e., located up to the
splenic flexure) we performed right hemicolectomy ex-
tended to the mid-transverse colon with lymphadenectomy
at the origin of the ileocolic, right colic, and middle colic
arteries when necessary. We performed left hemicolectomy
plus high anterior rectal resection for distal tumors (i.e.,
located from the splenic flexure to the rectal-sigmoid junc-
tion) and lymphadenectomy was extended to the origin of
the inferior mesenteric vessels. A distal clearance of at least
2 cm of healthy mucosa from the lower edge of the tumors
was provided in all cases.
Pathological examination
Pathology staff and examination technique of surgical
specimens did not change during the entire period of
study. All the surgical specimens were fixed in 10% for-
malin solution and routinely processed for paraffin em-
bedding. Tumor stage was determined according to the
sixth edition of the American Joint Committee of Cancer
(AJCC) staging system [20]. The number of examined
lymph nodes (LNs) was ascertained by reference to the
histopathology report of each patient. Lymph nodes were
identified in the mesocolic fat of the surgical specimens by
sight and palpation. Routine histologic examination was
performed using hematoxylin and eosin staining. Histo-
logic processing of the specimens was the same for all pa-
tients. No special fat clearance or staining techniques were
employed. The following histopathological features were
Table 1 Comparison of clinical outcomes between
patients of the open and laparoscopic groups
Open resection
(n =233)
Laparoscopic resection
(n=227)
P
Gender (M/F) 122/111 117/110 0.8*
Mean age (yr) 68.3 ± 0.9 70.0 ± 0.7 0.08§
Operative Mortality
(30 days)
4 (1.7) 3 (1.3) 0.7*
Overall
postoperative
complications (%)
41 (17.6) 16 (7.0) <0.01*
Total grade I 5 (2.2) 0
Wound infection 5 0
Total grade II 24 (10.3) 9 (4.0)
Urinary retention/
infection
1 0
Arrhythmia 5 4
Pneumonia 4 2
Ileus 10 1
Deep vein thrombosis 3 0
Cerebrovascular
accident
1 1
Pancreatitis 0 1
Total Grade III 11 (4.7) 6 (2.6)
Intestinal obstruction 4 1
Gastrointestinal
bleeding
3 2
Anastomotic leak 4 3
Total Grade IV 1 (0.4) 1(0.4)
Cardiac failure 1 1
Median hospital
stay (days)
9 (5-16) 6 (3-10) <0.05§
Tumor site (%) 0.9*
Proximal tumors 130 (56.8) 127 (56.0)
Distal tumors 103 (44.2) 100 (44.0)
Tumor type (%) 0.7*
Adenocarcinoma 190 (81.5) 182 (80.2)
Mucinous carcinoma 43 (18.5) 45 (19.8)
Tumor differentiation
(%)
0.3°
Well differentiated 25 (13.1) 16 (7.0)
Moderately
differentiated
152 (65.2) 155 (68.2)
Poorly differentiated 13 (5.5) 11 (4.9)
Tumor stage (%) <0.01°
I 35 (15.0) 64 (30.7)
II 123 (45.8) 82 (35.1)
III 75 (35.9) 81 (34.1)
*Fisher’s exact test.
§Mann-Whitney test.
°Chi-square test.
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as adenocarcinoma or mucinous carcinoma if more than
50% of the tumor volume was composed of mucin) and
tumor differentiation (only for adenocarcinomas, classified
as well, moderately or poorly differentiated).
Statistical analysis
Cancer-related survival was calculated from the date of
the operation to the date of death due to cancer in
patients who had curative surgery. Alive patients, with
or without evidence of recurrent disease or lost to
follow-up were censored at the date last known to be
alive. Patients without evidence of recurrence at death
were censored at the date of death. The analysis was
performed on a treatment-received basis when compar-
ing data on patients undergoing either laparoscopic or
open resection. Categorical variables within laparoscopic
and open groups were compared using Fisher’s exact
test or the chi-square test. Quantitative variables were
summarized by mean and SEM or median and range.
Groups were compared using the Mann-Whitney test.
Differences in survival between groups were compared
using Kaplan-Meier curves and tested with the log rank
test. Statistical significance was considered if P < 0.05.
STATA Statistical Software release 6.0 (College Station,
TX, USA) was used for all the analyses.
Results
Between January 2002 and December 2010, 460 patients
underwent curative resection for non-metastatic colon
cancer. A total of 227 resections (49.3%) were performed
by the laparoscopic approach, whereas 233 patients
(50.7%) underwent open resections. All operations were
performed in an elective setting and patients with emer-
gency operations were excluded. All patients with stage
III tumors underwent adjuvant chemotherapy. Five pa-
tients (1.0%), 3 in the open and 2 in the laparoscopic
group, were lost to follow-up 2 years after the operation.
The median length of follow-up after laparoscopic resection
was 42.0 months (range, 3-120) compared with 50.0 months
(range, 4-120) after open resection.
The groups of patients who underwent open and lap-
aroscopic surgery did not significantly differ according
to gender and age (Table 1). The operative mortality rate
was 1.7% in the open and 1.3% in the laparoscopic group
(P = 0.7). The incidence of postoperative complications
was significantly lower after laparoscopic resection than
after open surgery (Table 1). The median length of post-
operative stay was significantly shorter at 6 days follow-
ing laparoscopic surgery compared with 9 days following
open resection (Table 1). There was no significant differ-
ence between the two groups in terms of tumor site,
histotype or differentiation (Table 1). Stage I tumors
were more frequent in the laparoscopic than in the open
Figure 1 Comparison of cancer-related survival of patients who
underwent laparoscopic and open surgery for colon cancer.
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the open than in the laparoscopic group (Table 1). The
overall average number of examined LNs per case was
significantly higher in the laparoscopic than in the open
group (Table 2). This result was also confirmed when
the number of examined LNs was compared between
each TNM stage category (Table 2). There was no sig-
nificant difference in the number of positive LNs for
stage III tumors between the two groups (Table 2).
The 5-year cancer-related survival for patients under-
going laparoscopic resection was significantly higher
than that for patients receiving open resections (83.1%
vs 68.5%, P = 0.01) (Figure 1). The comparison of sur-
vival of patients with stage I, II and III diseases is shown
in Figures 2A,B and C, respectively. There was no differ-
ence in survival in patients with stage I disease. The
improvement in survival in the laparoscopic group
occurred mainly in patients with stage II tumors: the
5-year survival rates were 75.8% and 90.7% for the open
and laparoscopic groups, respectively (P = 0.03). There
was also a trend towards better survival in patients with
stage III tumors, although it did not show any statistical
significance.
Discussion
Laparoscopic technique has revolutionized the treatment
of colorectal malignancy in recent years. Randomized con-
trolled trials have clearly shown that laparoscopy provides
favorable operative outcomes in terms of less pain, quick
recovery of the gastrointestinal tract, a shorter hospital
stay and cosmetic satisfaction when compared with open
surgery [2,3,6]. Moreover, a recent meta-analysis [21] and
two large retrospective studies [22,23] which included a
large number of patients, were also able to demonstrate a
significant reduction in mortality rate and lower morbidity
after laparoscopic resection.
Survival is the most important outcome for assessing
treatment success for malignant disease. Three major,
randomized trials have shown that laparoscopic resection
can produce an equivalent oncological outcome to that
achieved with open surgery but did not identify a survivalTable 2 Analysis of lymph node harvest between patients
of the open and laparoscopic groups
Open resection
(n =233)
Laparoscopic
resection(n = 227)
P
Harvested lymph
nodes (total)
14.2 ± 0.5 20.0 ± 0.7 <0.01§
Stage I 11.8 ± 1.0 18.1 ± 1.5 0.01§
Stage II 14.4 ± 0.7 21.8 ± 1.1 <0.01§
Stage III 14.9 ± 0.9 19.8 ± 1.0 <0.01§
Involved lymph
nodes
3.9 ± 0.3 3.3 ± 0.8 0.6§
§Mann-Whitney test.advantage in favor of laparoscopy [2,6,7]. In a single-
center randomized study, Lacy et al. [10] have shown a
cancer-related survival advantage after laparoscopic sur-
gery for stage III colon cancer. Capussotti et al. [24] also
found that laparoscopic resection was associated with sig-
nificantly better disease-free and cancer-related survival
in patients with stage III colon cancer. Other groups have
recently reported superior survival for patients undergoing
laparoscopic resection, even for those with stage II colorectal
cancer [25]. All these studies have distinguished between
colon and rectal cancer in their survival analysis, showing an
improvement in survival after laparoscopic resection mostly
in the colon cancer patients.
In the present study, we found overall better survival
for patients who had undergone laparoscopic resection
for colon cancer. However, the study is retrospective
and the difference in follow-up period between the two
study groups as well biases in the selection of patients
were unavoidable and might affect our survival analysis.
In particular, the two groups of study patients were not
homogeneous regarding tumor stage: stage I tumors
were more frequent in the laparoscopic group whereas
stage II tumors were more frequent in the open one. As
a consequence, a stage-to-stage comparison was made
between the two groups of patients. Interestingly, we
found that improvement in survival was limited to
patients undergoing laparoscopic resection for stage II
tumors.
One of the reasons accounting for this better survival
might be the difference in LN harvesting between the
two groups of patients. Indeed, we found that the num-
ber of retrieved and examined LNs was significantly
higher in patients who had undergone laparoscopic
resection. This finding is particularly relevant if we con-
sider that the mean values of LNs found in our patients,
both in the open and laparoscopic group, are among the
Figure 2 Comparison of cancer-related survival of patients who
underwent laparoscopic and open surgery according to tumor
stage. A) Comparison of cancer-related survival of patients who
underwent laparoscopic and open surgery for stage I colon cancer. B)
Comparison of cancer-related survival of patients who underwent
laparoscopic and open surgery for stage II colon cancer. C) Comparison
of cancer-related survival of patients who underwent laparoscopic and
open surgery for stage III colon cancer.
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threshold value of 12 LNs recommended by the AJCC
[26]. It is well known that appropriate lymphadenectomy
during colorectal cancer surgery is crucial for the pa-
tient’s oncological outcome for at least two reasons.
First, it reduces the risk of residual nodal disease, and
second, only the examination of a large number of LNs
can predict accurate nodal staging. Our finding of im-
proved survival only in patients with stage II, i.e. T3N0,colon cancer underlines the importance of an adequate
number of harvested LNs so as to reduce the risk of
overlooking one or more metastatic LNs in the surgical
specimens. Therefore, better stratification of our stage
II patients within the laparoscopic group may explain
the survival advantage when compared with the open
surgery patients.
Recently, similar results have been reported by Law
et al. [25]. Among their 814 patients who had undergone
laparoscopic resection for both colon and rectal cancer,
they found an improvement in survival only in patients
with stage II disease in comparison with the open group
patients (n = 1197). Even in this series of patients, there
were significantly more LNs examined in the laparo-
scopic than in the open group (median value, 13 vs 11 in
the two groups, respectively).
As already discussed in a previously published study
[19], we do not have a clear explanation for the better
accuracy in LN retrieval after laparoscopic resection.
Some authors have stated that laparoscopy for colorectal
cancer offers the opportunity for a meticulous dissection
of the mesocolon and mesorectum under direct vision
while facilitating an accurate lymphadenectomy [27,28].
However, other factors may influence the number of
examined LNs in cancer specimens. The experience of
the surgeon performing the operations and the skill
of the pathologist in retrieving LNs are considered the
most important among these factors [29-31]. In our
study, the majority of open procedures were performed
by one surgeon skilled in gastrointestinal surgery and
the same operative techniques, especially the same types
of lymphadenectomy, were exactly reproduced laparo-
scopically by the other two surgeons. Histopathologic
examination remained uniform during the study with no
changes in the pathologic team or in LN harvesting
technique. One possible explanation is that the prognostic
importance of the number of retrieved LNs in colorectal
cancer specimens was emphasized by the AJCC [26] only
at the beginning of the 2000s and thus, the increase in the
number of harvested LNs in our more recent laparoscopic
experience may be due to a greater effort by both the
surgeons and the pathologists to remove and examine the
maximum number of LNs.
Other reasons might account for the better survival
observed in patients who underwent laparoscopic surgery
for colon cancer. One of the most important of these might
be the prompt preservation of the patient’s immunological
response against cancer from the first postoperative days
[32]. This is mainly due to the reduced inflammatory stress
and thus the reduced inhibition of cell-mediated immunity
observed after laparoscopic surgery [15]. Moreover, a
number of studies have demonstrated that cancer-prone
cytokines, such as interleukin 6 and vascular endothelial
growth factor, are produced significantly more after open
Cianchi et al. BMC Surgery  (2015) 15:33 Page 6 of 7than laparoscopic surgery [16,33]. Altogether, these data
might help to explain our better oncologic outcome after
laparoscopic resection.
Conclusions
Within the limitations of a retrospective analysis, our
study shows a survival advantage for patients undergoing
laparoscopic surgery for stage II colon cancer. This may be
correlated with a higher number of harvested/examined
LNs and thus a better stage stratification of these patients
when compared with the open group. However, other
reasons, such as a more efficient postoperative immune
response, might be involved.
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